Evaluates safety and sustained weight loss with liraglutide in obese adults, indicating promising long-term outcomes.
Having demonstrated short-term weight loss with liraglutide in this group of obese adults, we now evaluate safety/tolerability (primary outcome) and long-term efficacy for sustaining weight loss (secondary outcome) over 2 years.
No takes yet. Share an insight, caveat, or question.
Astrup et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: